Sedat Ustundag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sedat Ustundag has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Saniye Sen
4 shared publicationsBora Demirkan
Trakya University Faculty of Medicine, Department of Biochemistry, Edirne, Turkey
3 shared publications- Arzu Ay
Department of Biophysics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey
2 shared publications - Cevat Aktas
Department of Histology and Embryology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
2 shared publications Gulay Yilmaz
A Department of Nephrology
2 shared publications- Gulizar Sahin
Department of Nephrology, Sultan Abdulhamid Han Research and Training Hospital, University of Health Sciences, 34668 Istanbul, Turkey
2 shared publications
Latest Publications
- 20 September 2026
- Published by Springer Nature in Journal of Ultrasound
- Vol. 29 (4) , 855-863
Combined ultrasonographic and clinical assessment of bioimpedance-defined volume status in dialysis patients: a diagnostic accuracy study
- 20 September 2026
- Published by Springer Nature in Journal of Ultrasound
- Vol. 29 (4) , 855-863
Combined ultrasonographic and clinical assessment of bioimpedance-defined volume status in dialysis patients: a diagnostic accuracy study
- 30 September 2025
- Published by Turk Nefroloji, Diyaliz ve Transplantasyon Hemsireleri Dernegi in Turk Nefroloji, Diyaliz ve Transplantasyon Hemsireleri Dernegi
Evaluation of Comfort Levels and Nursing Care Satisfaction of Patients Receiving Hemodialysis /Hemodiyaliz Hastalarının Konfor Düzeyleri ve Hemşirelik Bakımından Memnuniyetlerinin Değerlendirilmesi
Aim: To evaluate the comfort levels and satisfaction with nursing care of patients receiving hemodialysis treatment. Materials and Methods: A descriptive and cross-sectional study was conducted with 109 patients receiving hemodialysis in units of a university and a state hospital. Patients who had been receiving hemodialysis treatment for at least six months, had no communication difficulties, and voluntarily agreed to participate were included in the study. Data were collected using the “Hemodialysis Comfort Scale” and the “Newcastle Satisfaction with Nursing Care Scale”. Results: The mean age of the patients was 61.54±12.67 years. Among the participants, 62.4% were male, 72.5% were married, 85.3% had children, and 89.9% lived in nuclear families. Half of the participants (50.5%) were primary school graduates, 56.9% were retired, and 66.1% had a moderate income level. Participants’ disease duration was 6.80±7.54 years. The mean total score of the Hemodialysis Comfort Scale was 3.30±0.86, and the mean total score of the Newcastle Satisfaction with Nursing Care Scale was 82.40±16.37. Conclusion: This study found that the comfort levels of hemodialysis patients were moderate, while their satisfaction with nursing care was at high level. Nurses should periodically evaluate patients’ comfort and care satisfaction during hemodialysis.
- 30 September 2025
- Published by Turk Nefroloji, Diyaliz ve Transplantasyon Hemsireleri Dernegi in Turk Nefroloji, Diyaliz ve Transplantasyon Hemsireleri Dernegi
Evaluation of Comfort Levels and Nursing Care Satisfaction of Patients Receiving Hemodialysis /Hemodiyaliz Hastalarının Konfor Düzeyleri ve Hemşirelik Bakımından Memnuniyetlerinin Değerlendirilmesi
Aim: To evaluate the comfort levels and satisfaction with nursing care of patients receiving hemodialysis treatment. Materials and Methods: A descriptive and cross-sectional study was conducted with 109 patients receiving hemodialysis in units of a university and a state hospital. Patients who had been receiving hemodialysis treatment for at least six months, had no communication difficulties, and voluntarily agreed to participate were included in the study. Data were collected using the “Hemodialysis Comfort Scale” and the “Newcastle Satisfaction with Nursing Care Scale”. Results: The mean age of the patients was 61.54±12.67 years. Among the participants, 62.4% were male, 72.5% were married, 85.3% had children, and 89.9% lived in nuclear families. Half of the participants (50.5%) were primary school graduates, 56.9% were retired, and 66.1% had a moderate income level. Participants’ disease duration was 6.80±7.54 years. The mean total score of the Hemodialysis Comfort Scale was 3.30±0.86, and the mean total score of the Newcastle Satisfaction with Nursing Care Scale was 82.40±16.37. Conclusion: This study found that the comfort levels of hemodialysis patients were moderate, while their satisfaction with nursing care was at high level. Nurses should periodically evaluate patients’ comfort and care satisfaction during hemodialysis.
- Open Access
- 8 June 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-9
Pre-earthquake kidney function is a predictor of outcomes in earthquake-related crush syndrome
The devastating earthquakes in Kahramanmaraş, Türkiye, in February 2024, caused extensive trauma and loss of lives, causing unique challenges in the management of earthquake-related crush syndrome. The current study investigates the prognostic value of pre-earthquake kidney function for mortality prediction in patients diagnosed with crush syndrome. A multi-center retrospective analysis was performed using data from 469 patients treated at 46 nephrology clinics. Pre-earthquake Kidney function, defined by serum creatinine and estimated glomerular filtration rate (eGFR) levels, was obtained from pre-earthquake health records. Clinical findings, laboratory parameters, complications, and survival probabilities were analyzed. Multivariate Cox regression was used to identify independent predictors of in-hospital mortality. The mean age of participants was 42.56 ± 16.92 years (Non-survivors: 50.46 ± 20.03 years, Survivors: 42.34 ± 16.80 years (p = 0.172)). The in-hospital mortality rate was 2.8%. Non-survivors exhibited significantly higher pre-earthquake creatinine levels than survivors (1.04 ± 0.61 mg/dL vs. 0.77 ± 0.33 mg/dL, p = 0.03), with lower eGFR (85.2 ± 34.7 mL/min/1.73 m² vs. 115.8 ± 39.4 mL/min/1.73 m², p = 0.008). Compared with survivors, non-survivors had higher incidences of AKI (92.3% vs. 61.6%, p = 0.037) and more severe metabolic disturbances, including hyperkalemia (5.41 ± 1.72 mmol/L vs. 5.13 ± 0.98 mmol/L, p = 0.008). Regression analysis revealed that pre-earthquake creatinine (HR: 9.121, 95% CI: 2.686–30.970, p < 0.001) and potassium levels at admission (HR: 3.338, 95% CI: 1.540–7.232, p = 0.002) were independent predictors of mortality. Pre-earthquake kidney function significantly predicts mortality in crush syndrome patients, highlighting the importance of baseline kidney assessment in disaster preparedness.
- 8 June 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-9
Open AccessPre-earthquake kidney function is a predictor of outcomes in earthquake-related crush syndrome
The devastating earthquakes in Kahramanmaraş, Türkiye, in February 2024, caused extensive trauma and loss of lives, causing unique challenges in the management of earthquake-related crush syndrome. The current study investigates the prognostic value of pre-earthquake kidney function for mortality prediction in patients diagnosed with crush syndrome. A multi-center retrospective analysis was performed using data from 469 patients treated at 46 nephrology clinics. Pre-earthquake Kidney function, defined by serum creatinine and estimated glomerular filtration rate (eGFR) levels, was obtained from pre-earthquake health records. Clinical findings, laboratory parameters, complications, and survival probabilities were analyzed. Multivariate Cox regression was used to identify independent predictors of in-hospital mortality. The mean age of participants was 42.56 ± 16.92 years (Non-survivors: 50.46 ± 20.03 years, Survivors: 42.34 ± 16.80 years (p = 0.172)). The in-hospital mortality rate was 2.8%. Non-survivors exhibited significantly higher pre-earthquake creatinine levels than survivors (1.04 ± 0.61 mg/dL vs. 0.77 ± 0.33 mg/dL, p = 0.03), with lower eGFR (85.2 ± 34.7 mL/min/1.73 m² vs. 115.8 ± 39.4 mL/min/1.73 m², p = 0.008). Compared with survivors, non-survivors had higher incidences of AKI (92.3% vs. 61.6%, p = 0.037) and more severe metabolic disturbances, including hyperkalemia (5.41 ± 1.72 mmol/L vs. 5.13 ± 0.98 mmol/L, p = 0.008). Regression analysis revealed that pre-earthquake creatinine (HR: 9.121, 95% CI: 2.686–30.970, p < 0.001) and potassium levels at admission (HR: 3.338, 95% CI: 1.540–7.232, p = 0.002) were independent predictors of mortality. Pre-earthquake kidney function significantly predicts mortality in crush syndrome patients, highlighting the importance of baseline kidney assessment in disaster preparedness.
- Open Access
- 18 April 2024
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (1) , 2341787
Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group
Immunoglobulin A (IgA) nephropathy (IgAN) treatment consists of maximal supportive care and, for high-risk individuals, immunosuppressive treatment (IST). There are conflicting results regarding IST. Therefore, we aimed to investigate IST results among IgAN patients in Turkiye. The data of 1656 IgAN patients in the Primary Glomerular Diseases Study of the Turkish Society of Nephrology Glomerular Diseases Study Group were analyzed. A total of 408 primary IgAN patients treated with IST (65.4% male, mean age 38.4 ± 12.5 years, follow-up 30 (3-218) months) were included and divided into two groups according to treatment protocols (isolated corticosteroid [CS] 70.6% and combined IST 29.4%). Treatment responses, associated factors were analyzed. Remission (66.7% partial, 33.7% complete) was achieved in 74.7% of patients. Baseline systolic blood pressure, mean arterial pressure, and proteinuria levels were lower in responsives. Remission was achieved at significantly higher rates in the CS group (78% vs. 66.7%, p = 0.016). Partial remission was the prominent remission type. The remission rate was significantly higher among patients with segmental sclerosis compared to those without (60.4% vs. 49%, p = 0.047). In the multivariate analysis, MEST-C S1 (HR 1.43, 95% CI 1.08-1.89, p = 0.013), MEST-C T1 (HR 0.68, 95% CI 0.51-0.91, p = 0.008) and combined IST (HR 0.66, 95% CI 0.49-0.91, p = 0.009) were found to be significant regarding remission. CS can significantly improve remission in high-risk Turkish IgAN patients, despite the reliance on non-quantitative endpoints for favorable renal outcomes. Key predictors of remission include baseline proteinuria and specific histological markers. It is crucial to carefully weigh the risks and benefits of immunosuppressive therapy for these patients.
- 18 April 2024
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (1) , 2341787
Open AccessImmunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group
Immunoglobulin A (IgA) nephropathy (IgAN) treatment consists of maximal supportive care and, for high-risk individuals, immunosuppressive treatment (IST). There are conflicting results regarding IST. Therefore, we aimed to investigate IST results among IgAN patients in Turkiye. The data of 1656 IgAN patients in the Primary Glomerular Diseases Study of the Turkish Society of Nephrology Glomerular Diseases Study Group were analyzed. A total of 408 primary IgAN patients treated with IST (65.4% male, mean age 38.4 ± 12.5 years, follow-up 30 (3-218) months) were included and divided into two groups according to treatment protocols (isolated corticosteroid [CS] 70.6% and combined IST 29.4%). Treatment responses, associated factors were analyzed. Remission (66.7% partial, 33.7% complete) was achieved in 74.7% of patients. Baseline systolic blood pressure, mean arterial pressure, and proteinuria levels were lower in responsives. Remission was achieved at significantly higher rates in the CS group (78% vs. 66.7%, p = 0.016). Partial remission was the prominent remission type. The remission rate was significantly higher among patients with segmental sclerosis compared to those without (60.4% vs. 49%, p = 0.047). In the multivariate analysis, MEST-C S1 (HR 1.43, 95% CI 1.08-1.89, p = 0.013), MEST-C T1 (HR 0.68, 95% CI 0.51-0.91, p = 0.008) and combined IST (HR 0.66, 95% CI 0.49-0.91, p = 0.009) were found to be significant regarding remission. CS can significantly improve remission in high-risk Turkish IgAN patients, despite the reliance on non-quantitative endpoints for favorable renal outcomes. Key predictors of remission include baseline proteinuria and specific histological markers. It is crucial to carefully weigh the risks and benefits of immunosuppressive therapy for these patients.
- Open Access
- 26 December 2023
- Published by Trakya テ從iversitesi Faculty of Health Sciences in Balkan Sağlık Bilimleri Dergisi
- Vol. 2 (3) , 131-139
Comparison of Prevalence and Severity of Depressive Symptoms in Hemodialysis Patients Before and During The Covid-19 Pandemic
Amaç: Hemodiyaliz hastalarında COVID-19 salgını öncesi ve sırasında depresif belirtilerin varlığını ve şiddetini incelemek ve pandemi ile ilişkisini değerlendirmek. Gereç ve Yöntem: Bu çalışma, Eylül 2018-Haziran 2021 tarihleri arasında Beck depresyon anketi uygulanan 21 yetişkin hemodiyaliz hastası ile retrospektif olarak gerçekleştirildi. BDE skorlarının normal dağılıma uygunluğu Shapiro-Wilk testi ile değerlendirildi. 3 farklı tekrarlı ölçüm zamanı arasındaki BDÖ skorlarını karşılaştırmak için Friedman testi, çoklu karşılaştırmalar için Bonferroni düzeltmeli Dunn testi kullanıldı. Hastaların depresyon durumunu (hayır ve evet) 3 farklı tekrarlanan ölçüm periyodu arasında karşılaştırmak için Cochran Q testi kullanıldı. P değeri <0.05 istatistiksel olarak anlamlı kabul edildi. Bulgular: 21 hastanın (16 erkek, 5 kadın) yaş ortalaması 66,6±9,6 yıl olup, yaşları 48 ile 84 arasında değişmektedir. Hastaların %23,8'i kadın, %76,2'si erkekti. COVID-19 salgını sırasında BDE skorlarının pandemi öncesine göre anlamlı derecede yüksek olduğu görüldü (p < 0,001; Tablo 1 ve Şekil 2). COVID-19 salgını sırasında depresif belirtilerin şiddeti kadınlarda erkeklere göre oldukça yüksekti (p = 0,038). Sonuç: COVID-19 salgını hemodiyaliz hastalarında BDI skorlarını artırdı. Hemodiyaliz hastalarının rutin takibinde Beck Depresyon Anketi'nin uygulanmasının, depresyona girebilecek hastaların erken tanınmasına, gerekli tedavilerin sağlanmasına ve hemodiyaliz tedavisine uyumun artmasına önemli katkı sağlayacağını düşünüyoruz.
- 26 December 2023
- Published by Trakya テ從iversitesi Faculty of Health Sciences in Balkan Sağlık Bilimleri Dergisi
- Vol. 2 (3) , 131-139
Open AccessComparison of Prevalence and Severity of Depressive Symptoms in Hemodialysis Patients Before and During The Covid-19 Pandemic
Amaç: Hemodiyaliz hastalarında COVID-19 salgını öncesi ve sırasında depresif belirtilerin varlığını ve şiddetini incelemek ve pandemi ile ilişkisini değerlendirmek. Gereç ve Yöntem: Bu çalışma, Eylül 2018-Haziran 2021 tarihleri arasında Beck depresyon anketi uygulanan 21 yetişkin hemodiyaliz hastası ile retrospektif olarak gerçekleştirildi. BDE skorlarının normal dağılıma uygunluğu Shapiro-Wilk testi ile değerlendirildi. 3 farklı tekrarlı ölçüm zamanı arasındaki BDÖ skorlarını karşılaştırmak için Friedman testi, çoklu karşılaştırmalar için Bonferroni düzeltmeli Dunn testi kullanıldı. Hastaların depresyon durumunu (hayır ve evet) 3 farklı tekrarlanan ölçüm periyodu arasında karşılaştırmak için Cochran Q testi kullanıldı. P değeri <0.05 istatistiksel olarak anlamlı kabul edildi. Bulgular: 21 hastanın (16 erkek, 5 kadın) yaş ortalaması 66,6±9,6 yıl olup, yaşları 48 ile 84 arasında değişmektedir. Hastaların %23,8'i kadın, %76,2'si erkekti. COVID-19 salgını sırasında BDE skorlarının pandemi öncesine göre anlamlı derecede yüksek olduğu görüldü (p < 0,001; Tablo 1 ve Şekil 2). COVID-19 salgını sırasında depresif belirtilerin şiddeti kadınlarda erkeklere göre oldukça yüksekti (p = 0,038). Sonuç: COVID-19 salgını hemodiyaliz hastalarında BDI skorlarını artırdı. Hemodiyaliz hastalarının rutin takibinde Beck Depresyon Anketi'nin uygulanmasının, depresyona girebilecek hastaların erken tanınmasına, gerekli tedavilerin sağlanmasına ve hemodiyaliz tedavisine uyumun artmasına önemli katkı sağlayacağını düşünüyoruz.
- 31 August 2022
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 27 (2) , 240-245
The role of eNOS gene polymorphisms on contrast induced nephropathy development in chronic kidney disease patients
Introduction: Contrast nephropathy is a result of contrast media given through intravascular routes. Nitric oxide gene polymorphisms may alter the hemodynamic stability resulting in medullary ischemia Nitric oxide gene polymorphisms may have an enhancing role in contrast media related renal injury. The aim of this study was to investigate the role of eNOS intron 4a/b, T786C, and G894T gene polymorphisms on contrast‐nephropathy risk.Methods: Ninety‐four chronic kidney disease patients with contrast nephropathy and 120 chronic kidney disease patients without contrast nephropathy were included. DNA isolation was performed and specific regions of DNA for eNOS G894T, T786C, and intron 4a/b genes were amplified by polymerase chain reaction technique.Results: TT polymorphism of T786C gene and GG polymorphism of G894T gene were detected to be possibly protective from contrast induced nephropathy.Conclusion: Endothelial nitric oxide synthase G894T gene polymorphisms, older age, and presence of diabetes mellitus may influence contrast nephropathy development.
- 31 August 2022
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 27 (2) , 240-245
The role of eNOS gene polymorphisms on contrast induced nephropathy development in chronic kidney disease patients
Introduction: Contrast nephropathy is a result of contrast media given through intravascular routes. Nitric oxide gene polymorphisms may alter the hemodynamic stability resulting in medullary ischemia Nitric oxide gene polymorphisms may have an enhancing role in contrast media related renal injury. The aim of this study was to investigate the role of eNOS intron 4a/b, T786C, and G894T gene polymorphisms on contrast‐nephropathy risk.Methods: Ninety‐four chronic kidney disease patients with contrast nephropathy and 120 chronic kidney disease patients without contrast nephropathy were included. DNA isolation was performed and specific regions of DNA for eNOS G894T, T786C, and intron 4a/b genes were amplified by polymerase chain reaction technique.Results: TT polymorphism of T786C gene and GG polymorphism of G894T gene were detected to be possibly protective from contrast induced nephropathy.Conclusion: Endothelial nitric oxide synthase G894T gene polymorphisms, older age, and presence of diabetes mellitus may influence contrast nephropathy development.
- 7 June 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (2) , 1317-1326
The roles of MTHFR (C677T, A1298C) and MGP (G-7A, T-138C) gene variations in development of diabetic nephropathy in patients with type 2 diabetes mellitus
Background The goal of this study is to determine the role of MTHFR (C677T, A1298C) and MGP (G-7A, T-138C) gene variations in DN development. Methods There were 61 DN patients and 55 healthy controls in this study. The genotype distributions of these gene variations were determined using PCR and RFLP methods. Results According to our study, there was no significant relationship between these gene variations and DN (p > 0.05). The allele frequencies of the MTHFR C677T gene variation in the control group were found significantly different from the Hardy-Weinberg distribution (p < 0.05). According to combined genotype analysis, GA-TT combined genotype of MGP (G-7A/T-138C) gene variations was observed significantly more in the patient group with DN. The GA-TT combined genotype of MGP (G-7A/T-138C) gene variations was differ significantly between these groups (OR: 2.359, %95 CI: 1.094–5.087, p = 0.028). Conclusion In our study, although MTHFR and MGP gene variations were not risk factors, the GA-TT combined genotype of the MGP (G-7A/T-138C) gene variation was detected as an important risk factor for DN.
- 7 June 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (2) , 1317-1326
The roles of MTHFR (C677T, A1298C) and MGP (G-7A, T-138C) gene variations in development of diabetic nephropathy in patients with type 2 diabetes mellitus
Background The goal of this study is to determine the role of MTHFR (C677T, A1298C) and MGP (G-7A, T-138C) gene variations in DN development. Methods There were 61 DN patients and 55 healthy controls in this study. The genotype distributions of these gene variations were determined using PCR and RFLP methods. Results According to our study, there was no significant relationship between these gene variations and DN (p > 0.05). The allele frequencies of the MTHFR C677T gene variation in the control group were found significantly different from the Hardy-Weinberg distribution (p < 0.05). According to combined genotype analysis, GA-TT combined genotype of MGP (G-7A/T-138C) gene variations was observed significantly more in the patient group with DN. The GA-TT combined genotype of MGP (G-7A/T-138C) gene variations was differ significantly between these groups (OR: 2.359, %95 CI: 1.094–5.087, p = 0.028). Conclusion In our study, although MTHFR and MGP gene variations were not risk factors, the GA-TT combined genotype of the MGP (G-7A/T-138C) gene variation was detected as an important risk factor for DN.
- 15 July 2021
- Published by Springer Nature in Biological Trace Element Research
- Vol. 200 (5) , 2040-2052
Investigation of the Relationship Between IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) Gene Variations and Serum Copper and Zinc Levels in Patients Diagnosed with Chronic Renal Failure
The aim of this study is to investigate the relationship between IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) gene variations and serum trace element levels in patients diagnosed with CRF. Genotype distributions of IL-18 (− 607 C/A, − 137 G/C) gene variations were determined by polymerase chain reaction (PCR) method. PCR-restriction fragment length polymorphism (RFLP) methods were used to determine the MMP-2 (− 1306 C/T) gene variation genotype distributions. Serum trace element levels were determined by atomic absorption spectrophotometer method. A significant difference was found between the CRF patient and healthy control groups in terms of genotype distributions of IL-18 (− 607 C/A) and MMP-2 (− 1306 C/T) gene variations (p < 0.05). The significant difference was found between the patient and control groups in terms of serum copper and zinc levels and copper/zinc ratio (p < 0.05). The significant difference was detected between patient and control groups in terms of copper and zinc levels and copper/zinc ratio according to IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) gene variations and genotype distributions (p < 0.05). In addition, significant difference was determined in terms of serum copper and zinc levels and copper/zinc ratio according to haplotypes of IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) gene variations between patient and control groups (p < 0.05). In conclusion, evaluation of IL-18 (− 607 C/A, − 137 G/C) and MMP-2 (− 1306 C/T) gene variations and serum trace element levels together is extremely important in terms of obtaining important biomarkers in CRF early diagnosis and progression.
- 15 July 2021
- Published by Springer Nature in Biological Trace Element Research
- Vol. 200 (5) , 2040-2052
Investigation of the Relationship Between IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) Gene Variations and Serum Copper and Zinc Levels in Patients Diagnosed with Chronic Renal Failure
The aim of this study is to investigate the relationship between IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) gene variations and serum trace element levels in patients diagnosed with CRF. Genotype distributions of IL-18 (− 607 C/A, − 137 G/C) gene variations were determined by polymerase chain reaction (PCR) method. PCR-restriction fragment length polymorphism (RFLP) methods were used to determine the MMP-2 (− 1306 C/T) gene variation genotype distributions. Serum trace element levels were determined by atomic absorption spectrophotometer method. A significant difference was found between the CRF patient and healthy control groups in terms of genotype distributions of IL-18 (− 607 C/A) and MMP-2 (− 1306 C/T) gene variations (p < 0.05). The significant difference was found between the patient and control groups in terms of serum copper and zinc levels and copper/zinc ratio (p < 0.05). The significant difference was detected between patient and control groups in terms of copper and zinc levels and copper/zinc ratio according to IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) gene variations and genotype distributions (p < 0.05). In addition, significant difference was determined in terms of serum copper and zinc levels and copper/zinc ratio according to haplotypes of IL-18 (− 607 C/A), IL-18 (− 137 G/C), and MMP-2 (− 1306 C/T) gene variations between patient and control groups (p < 0.05). In conclusion, evaluation of IL-18 (− 607 C/A, − 137 G/C) and MMP-2 (− 1306 C/T) gene variations and serum trace element levels together is extremely important in terms of obtaining important biomarkers in CRF early diagnosis and progression.
- 31 August 2015
- Published by Taylor & Francis in Renal Failure
- Vol. 37 (8) , 1285-1292
Carotid intima media thickness is independently associated with urinary sodium excretion in patients with chronic kidney disease
Atherosclerosis-induced premature vascular diseases are the leading cause of mortality among patients with chronic kidney disease (CKD). The pathogenetic mechanism of atherosclerosis in patients with CKD has not been fully explained. Experimental studies have demonstrated that high dietary sodium intake not only increases circulatory volume and blood pressure, but also facilitates development of atherosclerosis by reducing production-bioavailability of nitric oxide due to oxidative stress and accordingly by enhancing endothelial and arterial stiffness. In this study, we investigated the relationship between sodium consumption and carotid artery intima-media thickness, which is the indicator of atherosclerosis, by determining daily urinary sodium excretion, which is a reliable indicator of sodium consumption, in our patient group. Our patient group included 193 patients with stage 2–4 non-diabetic CKD and without a history of atherosclerotic disease. We determined that 77% of our patients have been consuming more than 2 g of sodium per day, which is the upper limit of sodium consumption recommended for patients with CKD. We determined a positive linear correlation between carotid artery intima-media thickness and patient age (p < 0.001), C-reactive protein (p < 0.001), urinary sodium excretion (p < 0.001), body mass index (p = 0.002), systolic blood pressure (p = 0.002), hemoglobin (p = 0.030), triglycerides (p = 0.043), and diastolic blood pressure (p = 0.049). We also found a negative linear correlation between carotid artery intima-media thickness and glomerular filtration rate (p = 0.008). We found that urinary sodium excretion is the determinant of intima-media thickness even if all factors associated with intima-media thickness are adjusted, and that intima-media thickness increases by 0.031 (0.004–0.059) mm per 2 g increase in daily sodium excretion, independent from overall factors (p = 0.025). Our results reveal a relation between urinary sodium excretion and carotid artery intima-media thickness and suggest that excessive sodium consumption predisposes development of atherosclerosis in patients with CKD.
- 31 August 2015
- Published by Taylor & Francis in Renal Failure
- Vol. 37 (8) , 1285-1292
Carotid intima media thickness is independently associated with urinary sodium excretion in patients with chronic kidney disease
Atherosclerosis-induced premature vascular diseases are the leading cause of mortality among patients with chronic kidney disease (CKD). The pathogenetic mechanism of atherosclerosis in patients with CKD has not been fully explained. Experimental studies have demonstrated that high dietary sodium intake not only increases circulatory volume and blood pressure, but also facilitates development of atherosclerosis by reducing production-bioavailability of nitric oxide due to oxidative stress and accordingly by enhancing endothelial and arterial stiffness. In this study, we investigated the relationship between sodium consumption and carotid artery intima-media thickness, which is the indicator of atherosclerosis, by determining daily urinary sodium excretion, which is a reliable indicator of sodium consumption, in our patient group. Our patient group included 193 patients with stage 2–4 non-diabetic CKD and without a history of atherosclerotic disease. We determined that 77% of our patients have been consuming more than 2 g of sodium per day, which is the upper limit of sodium consumption recommended for patients with CKD. We determined a positive linear correlation between carotid artery intima-media thickness and patient age (p < 0.001), C-reactive protein (p < 0.001), urinary sodium excretion (p < 0.001), body mass index (p = 0.002), systolic blood pressure (p = 0.002), hemoglobin (p = 0.030), triglycerides (p = 0.043), and diastolic blood pressure (p = 0.049). We also found a negative linear correlation between carotid artery intima-media thickness and glomerular filtration rate (p = 0.008). We found that urinary sodium excretion is the determinant of intima-media thickness even if all factors associated with intima-media thickness are adjusted, and that intima-media thickness increases by 0.031 (0.004–0.059) mm per 2 g increase in daily sodium excretion, independent from overall factors (p = 0.025). Our results reveal a relation between urinary sodium excretion and carotid artery intima-media thickness and suggest that excessive sodium consumption predisposes development of atherosclerosis in patients with CKD.
- Open Access
- 1 January 2015
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 6 (3) , 101-104
Pleuroperitoneal Leak Complicating Continuous Ambulatory Peritoneal Dialysis: A Case Report
Acute massive pleuroperitoneal leak-related hydrothorax is a rare, but life-threatening complication of continuous ambulatory peritoneal dialysis (CAPD). Hydrothorax develops right after the initiation of the CAPD or within a few days post-treatment. The late development of hydrothorax in patients treated with CAPD is quite rare. The interpretation of pleuroperitoneal leak-related hydrothorax as a volume overload and subsequent application of hypertonic peritoneal exchange worsen the clinical course and can lead to mortality. We here present the data from a patient who developed acute bilateral hydrothorax at the 16th month of CAPD treatment. J Med Cases. 2015;6(3):101-104 doi: http://dx.doi.org/10.14740/jmc2055w
- 1 January 2015
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 6 (3) , 101-104
Open AccessPleuroperitoneal Leak Complicating Continuous Ambulatory Peritoneal Dialysis: A Case Report
Acute massive pleuroperitoneal leak-related hydrothorax is a rare, but life-threatening complication of continuous ambulatory peritoneal dialysis (CAPD). Hydrothorax develops right after the initiation of the CAPD or within a few days post-treatment. The late development of hydrothorax in patients treated with CAPD is quite rare. The interpretation of pleuroperitoneal leak-related hydrothorax as a volume overload and subsequent application of hypertonic peritoneal exchange worsen the clinical course and can lead to mortality. We here present the data from a patient who developed acute bilateral hydrothorax at the 16th month of CAPD treatment. J Med Cases. 2015;6(3):101-104 doi: http://dx.doi.org/10.14740/jmc2055w